InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by CRYSTAL ROGER, Chief Executive Officer. Officer active across 1 companies, notably Opiant Pharmaceuticals, INC.. Aggregated, 9 filings have been recorded. Total volume traded: €154k. The latest transaction was filed on 27 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
06,667 shares0
Common Stock
SEC:0001385508-22-000103:0·
€46,3991,995 shares@ €23.257830.2% of flow
Common Stock
SEC:0001385508-22-000025:0·
€46,3991,995 shares@ €23.257860.4% of flow
Common Stock
SEC:0001385508-22-000025·
€28,4121,058 shares@ €26.854137.0% of flow
Common Stock
SEC:0001385508-22-000020·
€28,4121,058 shares@ €26.854118.5% of flow
Common Stock
SEC:0001385508-22-000020:0·
040,000 shares0
Common Stock
SEC:0001385508-22-000008:0·
040,000 shares0
Common Stock
SEC:0001385508-22-000008·
€1,992100 shares@ €19.91932.6% of flow
Common Stock par value $0.001
SEC:0001385508-21-000134·
Ideal exit: 13 Jun 2022 (T+270)
€1,992100 shares@ €19.91931.3% of flow
Common Stock par value $0.001
SEC:0001385508-21-000134:0·
Ideal exit: 13 Jun 2022 (T+270)
9 of 9 declarations
About CRYSTAL ROGER
Roger Crystal serves as Chief Executive Officer of Opiant Pharmaceuticals, Inc. In this role, he oversees the company's overall operations and defines its growth strategy. Roger brings extensive experience in the pharmaceutical sector, contributing to the direction and governance of Opiant. His commitment to innovation and operational efficiency is essential for the company's success.
